Until Labs
PrivateLast Round
Series A
Sep 22, 2025
Total Funding Raised
$48M
Company Overview
Until Labs operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Seed round in June 2024.
Until Labs is a biotechnology company that develops perfusion hardware, cryoprotective agents, and rewarming infrastructure for organ-scale reversible cryopreservation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Until Labs Comparables
Compare Until Labs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| X-Therma | 84% | |
| CryoStasis Inc. | 79% | |
| Bridge to Life | 75% |
For institutional investors. Book with your work email.
Until Labs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 22, 2025 | ||||
| Seed | Jun 6, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Until Labs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Field Ventures | Series A |
| Field Ventures | Series A |
| Founders Fund | Series A |
| Lux Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 22, 2025
$58M round led by Founders Fund.
- Jun 6, 2024
$48M raised in Seed round.
For institutional investors. Book with your work email.
Until Labs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Until Labs's valuation, stock price, and market status.
Is Until Labs a public or private company?
Until Labs is a private company.
What is the current stock price of Until Labs?
Until Labs is a private company, so its shares have no public market price. Caplight tracks Until Labs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Until Labs worth (valuation)?
Valuation information for Until Labs is not publicly available.
Can I buy Until Labs stock?
Until Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Until Labs's last funding round?
Until Labs's most recent funding round was Series A on September 22, 2025.
Who are the main investors in Until Labs?
Key investors in Until Labs include Founders Fund.
Will Until Labs IPO soon?
No public IPO plans have been announced for Until Labs.
How can I track Until Labs secondary market activity?
Caplight tracks bids, offers, and trades in Until Labs's shares on secondary markets.